rhealth
Private Company
Total funding raised: $10.5M
Overview
Founded in 2015 by Dr. Eugene Chan, rHEALTH is a pioneering diagnostics company commercializing portable, single-drop blood analyzers originally developed for NASA to monitor astronaut health in space. The company has a strong technical foundation, validated by successful on-orbit testing, numerous patents, and prestigious awards like the Qualcomm Tricorder XPRIZE. rHEALTH aims to transform point-of-care and remote diagnostics by providing lab-quality results autonomously and immediately, targeting both terrestrial healthcare and future space missions.
Technology Platform
Portable, single-drop blood analyzer using nanostrips, microfluidics, and laser detection for multiplexed, autonomous diagnostic testing. Derived from NASA spaceflight requirements.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
rHEALTH competes in the broad point-of-care diagnostics market against giants like Abbott (i-STAT), Roche, and Siemens, as well as newer entrants in lab-on-a-chip and wearable sensing. Its key differentiators are the breadth of tests from a single drop, full automation, and its unique validation for extreme environments via NASA.